Gene · 3822
Papers2,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell dissection of Merkel cell carcinoma heterogeneity unveils transcriptomic plasticity and therapeutic vulnerabilities. | Cell Rep Med | 2023 | 37421947 | PubTator, text mining | PubMed |
| Characterization of large-scale genomic differences in the first complete human genome. | Genome Biol | 2023 | 37403156 | PubTator, text mining | PubMed |
| Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies. | Genes Dis | 2023 | 37396514 | PubTator, text mining | PubMed |
| Transcriptional and chromatin profiling of human blood innate lymphoid cell subsets sheds light on HIV-1 pathogenesis. | EMBO J | 2023 | 37382276 | PubTator, text mining | PubMed |
| Prospects of Cytomegalovirus-Specific T-Cell Receptors in Clinical Diagnosis and Therapy. | Viruses | 2023 | 37376633 | PubTator, text mining | PubMed |
| Phenotypic Changes in T and NK Cells Induced by Sputnik V Vaccination. | Vaccines (Basel) | 2023 | 37376436 | PubTator, text mining | PubMed |
| Non-Classical HLA Class 1b and Hepatocellular Carcinoma. | Biomedicines | 2023 | 37371767 | PubTator, text mining | PubMed |
| Single-cell analysis reveals HBV-specific PD-1+CD8+ TRM cells in tumor borders are associated with HBV-related hepatic damage and fibrosis in HCC patients. | J Exp Clin Cancer Res | 2023 | 37353792 | PubTator, text mining | PubMed |
| Association between NKG2/KLR gene variants and epilepsy in Autism Spectrum Disorder. | J Neuroimmunol | 2023 | 37352688 | PubTator, text mining | PubMed |
| Fetal-maternal interactions during pregnancy: a 'three-in-one' perspective. | Front Immunol | 2023 | 37350956 | PubTator, text mining | PubMed |
| Identification of natural killer markers associated with fatal outcome in COVID-19 patients. | Front Cell Infect Microbiol | 2023 | 37342247 | PubTator, text mining | PubMed |
| NK Cells from Human Cytomegalovirus-Seropositive Individuals Have a Distinct Metabolic Profile That Correlates with Elevated mTOR Signaling. | J Immunol | 2023 | 37341510 | PubTator, text mining | PubMed |
| Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma. | Front Oncol | 2023 | 37333810 | PubTator, text mining | PubMed |
| Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoires. | Blood Adv | 2023 | 37327114 | PubTator, text mining | PubMed |
| Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer. | J Ovarian Res | 2023 | 37322531 | PubTator, text mining | PubMed |
| Canonical BAF complex activity shapes the enhancer landscape that licenses CD8+ T cell effector and memory fates. | Immunity | 2023 | 37315534 | PubTator, text mining | PubMed |
| Renal cell carcinoma escapes NK cell-mediated immune surveillance through the downregulation of DNAM-1. | Cancer Commun (Lond) | 2023 | 37314951 | PubTator, text mining | PubMed |
| Local γδ T cells: translating promise to practice in cancer immunotherapy. | Br J Cancer | 2023 | 37311978 | PubTator, text mining | PubMed |
| Comparison of the different anti-CD16 antibody clones in the activation and expansion of peripheral blood NK cells. | Sci Rep | 2023 | 37302991 | PubTator, text mining | PubMed |
| Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease. | Int J Mol Sci | 2023 | 37298547 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3822/papers?page=17